Search Results
226 items found for "Chronic obstructive pulmonary disease (COPD)"
- 📰 GPCR Weekly News, August 7 to 13, 2023
Submit a 1-minute abstract video using this form! technology with potential applications in chemical biology: a mini-review YAP/TAZ: Molecular pathway and disease therapy Primary cilia in skeletal development and disease Industry News Addex Reports 2023 Half Year Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases Reports Second-Quarter 2023 Financial Results, Provides Corporate Updates, and Reports Emerging Data from Chronic
- Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair
October 2022 "Systolic heart failure (HF) is a chronic clinical syndrome characterized by the reduction in cardiac function and still remains the disease with the highest mortality worldwide. Chronic human HF is characterized by several important neurohormonal perturbations, emanating from both GPCR signaling and regulation, as they pertain to modulation of cardiac function in the context of chronic
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
mesenchymal stem cells in multiple sclerosis patients Multiple sclerosis (MS) is a specific type of chronic immune-mediated disease in which the immune responses are almost run against the central nervous system Despite intensive research, a known treatment for MS disease yet to be introduced. Thus, the development of novel and safe medications needs to be considered for the disease management MSCs have several sources and they can be derived from the umbilical cord, adipose tissue, and bone marrow
- Therapeutic validation of an orphan G protein‐coupled receptor
as sensory perception, reproduction, development, growth, metabolism, and are also linked to major diseases , such as neuroinflammatory, metabolic and autoimmune diseases. including neuroinflammation (Audoy‐Remus et al., 2015), with ongoing clinical trials in idiopathic pulmonary GPR84 has been additionally proposed to be a potential biomarker in different inflammatory diseases ( GPR84 is a promising target to exploit and the investment in better tools to study its function in both disease
- Profiling Immune Cell and Platelet Transcriptomes
modulate inflammatory responses, offering potential therapeutic avenues for conditions such as autoimmune diseases and chronic inflammation. exploring the roles of these receptors in various pathological states, including cancer and infectious diseases
- 📰 GPCR Weekly News, July 1 to 7, 2024
for their investigation on Modulation of contextual fear acquisition and extinction by acute and chronic Important Deadlines: Abstract Submission: July 22, 2024. determines the potential of a GPCR for arrestin-biased agonism The roles of RGS proteins in cardiometabolic disease Receptor Responses to Sequential Injections of Pure and Mixed Sweeteners GPCRs involved in metabolic diseases signaling in murine brain tissue Modulation of contextual fear acquisition and extinction by acute and chronic
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
Molecular Endocrinology and Pharmacology Laboratory team who are investigating new ways to tackle the disease-inducing chronic inflammation that is linked to type 2 diabetes."
- Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its...
macrophages and monocytes, and play a critical role in neuroinflammatory conditions such as Alzheimer's disease and multiple sclerosis, in the recovery from central nervous system injuries, in several chronic, peripheral
- Exploring the Breakthroughs in GPCR Research
Important Deadlines: Abstract Submission: July 22, 2024. Submit your abstract today; the deadline is fast approaching! structural approach Mechanisms controlling haemolymph circulation under resting conditions in the chagas disease Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic , and more Class B1 GPCRs: Insights into Multi-Receptor Pharmacology for the Treatment of Metabolic Disease
- Statin-induced increase in actin polymerization modulates GPCR dynamics and compartmentalization
In a recent work, we reported that chronic cholesterol depletion using statins leads to significant polymerization understanding the modulatory role of the membrane environment on the organization and dynamics of GPCRs in diseases
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
context-dependent compared to the C5aR1, which has received enormous attention for its role in both acute and chronic inflammatory diseases.
- Regulators of G-protein signaling: essential players in GPCR signaling
Implications of RGS protein dysregulation in disease: The Dysregulation of RGS proteins has been implicated in a range of diseases, including cardiovascular disease, pain, hypertension, and cancer. In cardiovascular disease, RGS proteins play a critical role in regulating blood pressure and vascular The dysregulation of these proteins has been implicated in a range of diseases, and understanding the Avrampou, K., et al., RGS4 Maintains Chronic Pain Symptoms in Rodent Models.
- 📰 GPCR Weekly News
GPCR Activation and Signaling Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances
- Chemokine receptor-targeted drug discovery: progress and challenges
chemokine receptor system is implicated in a wide range of inflammatory, autoimmune and infectious diseases a single receptor as patients cannot be stratified into CKRs specific subpopulations for a specific disease rigorous for this class, as the majority of potential therapeutic applications are situated in the area of chronic inflammatory disease (Proudfoot, Power, and Schwarz 2010).
- 📰 GPCR Weekly News, March 13 to 19, 2023
The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary and Immunology Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
outstanding study on Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease challenges Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease for clinical development Chemokine CXCL13-CXCR5 signaling in neuroinflammation and pathogenesis of chronic pain and neurological diseases Structural and Molecular Insights into GPCR Function Native mass spectrometry
- 📰 GPCR Weekly News, March 27 to April 4, 2023
The program is under construction but if you’d like to give a talk or present a poster, email us at Hello First complete genome sequence of lumpy skin disease virus directly from a clinical sample in South India Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities. Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases
- Cholesterol-Dependent Dynamics of the Serotonin1A Receptor Utilizing Single Particle Tracking: ...
utilized single particle tracking (SPT) to monitor diffusion of serotonin1A receptors under acute and chronic in the confined population of the receptor accompanied by a reduction in diffusion coefficient for chronic supported by our recent work and present observations that show polymerization of G-actin in response to chronic
- 📰 GPCR Weekly News, May 20 to 26, 2024
Join the global GPCR community and share your research—submit your abstract using this form. Adhesion GPCRs Adhesion G Protein-Coupled Receptor Gpr126 (Adgrg6) Expression Profiling in Diseased Mouse protein-coupled receptor-associated proteins in the caudate and the putamen of cynomolgus macaques following chronic
- Cholesterol-Dependent Dynamics of the Serotonin 1A Receptor Utilizing Single Particle Tracking....
utilized single particle tracking (SPT) to monitor diffusion of serotonin1A receptors under acute and chronic in the confined population of the receptor accompanied by a reduction in diffusion coefficient for chronic supported by our recent work and present observations that show polymerization of G-actin in response to chronic
- 📰 GPCR Weekly News, June 24 to 30, 2024
Matthew Eddy, et al. for their investigation on Interaction Networks within Disease-Associated GαS Variants Important Deadlines: Abstract Submission: July 22, 2024. Submit your abstract today! receptor endocytosis generates spatiotemporal bias in β-arrestin signaling Interaction Networks within Disease-Associated Industry News Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
revealed by 19F NMR spectroscopy Role of protease activated receptor 4 (PAR4) in mouse models of acute and chronic screening of potential inhibitors of GPR52 using docking and biased sampling method for Huntington's disease Announces Start of First Clinical Program for GPCR-Targeted Biologic Trevena Announces Acceptance of Abstract
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
monoclonal antibodies for the treatment of cancer, infections, metabolic disorders or inflammatory diseases Recently, functional autoantibodies targeting GPCRs have been associated with various disease-specific is to bring together the current knowledge on the role of autoantibodies targeting GPCRs in various diseases , such as cardiovascular diseases, renal diseases, autoimmune diseases such as systemic sclerosis or
- Focusing on the role of secretin/adhesion (Class B) G protein-coupled receptors in placental...
high maternal mortality, is a risk factor highly associated with maternal and offspring cardiovascular disease Obesity, immunological diseases and endocrine metabolic diseases are high-risk factors for the development them, the secretin/adhesion (Class B) G protein-coupled receptors are essential drug targets for human diseases , such as endocrine diseases and cardiometabolic diseases.
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease Submit a 1-minute abstract video using this form. Taste Gene expression analyses of TAS1R taste receptors relevant to the treatment of cardiometabolic disease GPCRs in Neuroscience Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease development GPCRs in Oncology and Immunology GPCRs and fibroblast heterogeneity in fibroblast-associated diseases
- 📰 GPCR Weekly News, March 18 to 24, 2024
Alexander Hauser, Caroline Gorvin et al. for their research on GPCR gene variants and human genetic disease of glycosaminoglycans in GPCR signaling G protein-coupled receptor-mediated autophagy in health and disease organelles Reviews, GPCRs, and more G protein-coupled receptor (GPCR) gene variants and human genetic disease Heptares Doses First Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease
- Immunomodulatory Role of Neuropeptides in the Cornea
insights are made into the role of neuropeptides and their immunomodulatory functions in the healthy and diseased neuropeptides, receptor isoform-specific signaling events, and the inflammatory microenvironment in disease an increase in studies that have begun modulating neuropeptide activity for the treatment of corneal diseases focuses on the role of neuropeptides in maintaining the homeostasis of the ocular surface, alterations in disease
- G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions...
GRK2/β-arrestin2 play multiple roles in the pathological mechanisms of a wide range of diseases including heart failure, cancer, and inflammatory diseases. cell function and focuses on the pathological implications of GRK2/β-arrestin2 in various inflammatory diseases